METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma

Zhi-Wei Zhang 1, Xufei Teng 2, Fu Zhao 3, Chunhui Ma 1, Jing Zhang 4, Ling-Feng Xiao 1, Yaning Wang 5, Mengqi Chang 1, Yongji Tian 6, Chunde Li 3, Zhang Zhang 2, Shuhui Song 7, Wei-Min Tong 8, Pinan Liu 9, Yamei Niu 10

Cell Rep. 2022 Oct 25;41(4):111530. doi: 10.1016/j.celrep.2022.111530.

PMID: 36288719

Abstract

SHH subgroup medulloblastoma (SHH-MB) is one of the most common malignant pediatric tumors that arises in the cerebellum. Previously, we showed that RNA m6A methylation participates in regulation of cerebellar development. Here we investigate whether dysregulated m6A methylation contributes to tumorigenesis of SHH-MB. We show that high expression of m6A methyltransferase METTL3 associates with worse survival in the patients with SHH-MB. A large number of hypermethylated transcripts are identified in SHH-MB tumor cells by m6A-seq. We find that METTL3 promotes tumor progression via activating Sonic hedgehog signaling. Mechanistically, METTL3 methylates PTCH1 and GLI2 RNAs and further regulates their RNA stability and translation. Importantly, targeting METTL3 by depleting METTL3 expression or treatment with its catalytic inhibitor STM2457 restrains tumor progression. Collectively, this study shows a critical function for METTL3 and m6A methylation in SHH-MB, indicative of a potential role of METTL3 as therapeutic target in SHH-MB.